首页> 外国专利> mir-208 and mir-499 dual targeting in the treatment of heart disease.

mir-208 and mir-499 dual targeting in the treatment of heart disease.

机译:mir-208和mir-499双重靶向治疗心脏病。

摘要

The present invention provides a method of treating or preventing cardiac disorders in a subject in need thereof by inhibiting the expression or function of both miR-499 and miR-208 in the heart cells of the subject. In particular, specific protocols for administering inhibitors of the two miRNAs that achieve efficient, long-term suppression are disclosed. In addition, the invention provides a method for treating or preventing musculoskeletal disorders in a subject in need thereof by increasing the expression or activity of both miR-208 and miR-499 in skeletal muscle cells of the subject.
机译:本发明提供了一种通过抑制对象的心脏细胞中miR-499和miR-208的表达或功能而在有此需要的对象中治疗或预防心脏疾病的方法。特别地,公开了用于施用实现有效,长期抑制的两种miRNA的抑制剂的特定方案。另外,本发明提供了一种通过增加对象的骨骼肌细胞中miR-208和miR-499的表达或活性来治疗或预防有此需要的对象的肌肉骨骼疾病的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号